Andrew Mossine

Andrew Mossine is currently an Associate Director of Technical Operations at POINT Biopharma. Before that, Andrew held positions such as Sr. Chemist at POINT Biopharma, Chemist II at Curium Pharma, and Production/QC Chemist at Zevacor Molecular. Andrew's educational background includes a Doctor of Philosophy (PhD) in Chemistry and a Bachelor of Science (BS) in Chemistry, along with a minor in Mathematics, all obtained from the University of Missouri-Columbia. Andrew's previous work includes being a Postdoctoral Research Fellow at the University of Michigan Health System and a Graduate Research Assistant at the University of Missouri, focusing on synthesizing macrocyclic molecules and studying the effects of Bisphenol-A on zebrafish embryos.